123 related articles for article (PubMed ID: 21879817)
1. Changing attitudes in ovarian stimulation.
Al-Inany H; Wahba A; Peitsidis P
Womens Health (Lond); 2011 Sep; 7(5):505-7. PubMed ID: 21879817
[No Abstract] [Full Text] [Related]
2. Ovarian hyperstimulation: effects of GnRH analogues. Does triggering ovulation with gonadotrophin-releasing hormone analogue prevent severe ovarian hyperstimulation syndrome?
Casper RF
Hum Reprod; 1996 Jun; 11(6):1144-6. PubMed ID: 8671408
[No Abstract] [Full Text] [Related]
3. Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study.
Bodri D; Guillén JJ; Galindo A; Mataró D; Pujol A; Coll O
Fertil Steril; 2009 Feb; 91(2):365-71. PubMed ID: 18367175
[TBL] [Abstract][Full Text] [Related]
4. Gonadotropin-releasing hormone agonist combined with a reduced dose of human chorionic gonadotropin for final oocyte maturation in fresh autologous cycles of in vitro fertilization.
Shapiro BS; Daneshmand ST; Garner FC; Aguirre M; Thomas S
Fertil Steril; 2008 Jul; 90(1):231-3. PubMed ID: 17981269
[TBL] [Abstract][Full Text] [Related]
5. 1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study.
Humaidan P; Ejdrup Bredkjaer H; Westergaard LG; Yding Andersen C
Fertil Steril; 2010 Feb; 93(3):847-54. PubMed ID: 19200959
[TBL] [Abstract][Full Text] [Related]
6. Agonist trigger: what is the best approach? Agonist trigger and low dose hCG.
Humaidan P
Fertil Steril; 2012 Mar; 97(3):529-30. PubMed ID: 22154368
[TBL] [Abstract][Full Text] [Related]
7. Preventing ovarian hyperstimulation with gonadotropin-releasing hormone agonist trigger: is anything perfect?
Filicori M
Fertil Steril; 2014 Apr; 101(4):936-7. PubMed ID: 24613536
[No Abstract] [Full Text] [Related]
8. Comparison of "triggers" using leuprolide acetate alone or in combination with low-dose human chorionic gonadotropin.
Shapiro BS; Daneshmand ST; Garner FC; Aguirre M; Hudson C
Fertil Steril; 2011 Jun; 95(8):2715-7. PubMed ID: 21550042
[TBL] [Abstract][Full Text] [Related]
9. GnRH antagonist rescue of a long-protocol IVF cycle and GnRH agonist trigger to avoid ovarian hyperstimulation syndrome: three case reports.
Martínez F; Rodríguez DB; Buxaderas R; Tur R; Mancini F; Coroleu B
Fertil Steril; 2011 Jun; 95(7):2432.e17-9. PubMed ID: 21513932
[TBL] [Abstract][Full Text] [Related]
10. Ovarian hyperstimulation: effects of GnRH analogues. Triggering the final stage of ovulation using gonadotrophin-releasing hormone analogues: effective dose, prevention of ovarian hyperstimulation syndrome and the luteal phase.
Ben-Arie A; Weissman A; Shoham Z
Hum Reprod; 1996 Jun; 11(6):1146-8. PubMed ID: 8671409
[No Abstract] [Full Text] [Related]
11. Impact of coasting in patients undergoing controlled ovarian stimulation with the gonadotropin-releasing hormone antagonist cetrorelix.
Bahceci M; Ulug U; Tosun S; Erden HF; Bayazit N
Fertil Steril; 2006 May; 85(5):1523-5. PubMed ID: 16566935
[TBL] [Abstract][Full Text] [Related]
12. GnRH analogue for the prevention of ovarian hyperstimulation syndrome: a pilot study.
Giles J; Requena A; García-Velasco JA; Pacheco A; Pellicer J; Pellicer A
Fertil Steril; 2009 Apr; 91(4 Suppl):1366-9. PubMed ID: 18692821
[TBL] [Abstract][Full Text] [Related]
13. GnRHa to trigger final oocyte maturation: a time to reconsider.
Youssef M; van der Veen F; van Wely M
Hum Reprod; 2010 Feb; 25(2):559. PubMed ID: 19955105
[No Abstract] [Full Text] [Related]
14. Can FSH co-trigger prevent OHSS?
Rosen MP; Meldrum DR
Fertil Steril; 2012 Mar; 97(3):534-5. PubMed ID: 22285746
[TBL] [Abstract][Full Text] [Related]
15. No room for cancellation, coasting, or ovarian hyperstimulation syndrome in oocyte donation cycles.
Hernández ER; Gómez-Palomares JL; Ricciarelli E
Fertil Steril; 2009 Apr; 91(4 Suppl):1358-61. PubMed ID: 18555236
[TBL] [Abstract][Full Text] [Related]
16. [How to prevent completely ovarian hyperstimulation with GnRH-based stimulation protocols].
Kol S
Akush Ginekol (Sofiia); 2001; 40(4):36-41. PubMed ID: 11803870
[No Abstract] [Full Text] [Related]
17. Human chorionic gonadotropin vs. gonadotropin-releasing hormone agonist trigger in assisted reproductive technology--"the king is dead, long live the king!".
Humaidan P; Polyzos NP
Fertil Steril; 2014 Aug; 102(2):339-41. PubMed ID: 24907915
[No Abstract] [Full Text] [Related]
18. Prévention du syndrome d'hyperstimulation ovarienne.
Corbett S; Shmorgun D; Claman P
J Obstet Gynaecol Can; 2016 Dec; 38(12S):S512-S524. PubMed ID: 28063561
[No Abstract] [Full Text] [Related]
19. Prevention and management of ovarian hyperstimulation syndrome.
Chen CD; Chen SU; Yang YS
Best Pract Res Clin Obstet Gynaecol; 2012 Dec; 26(6):817-27. PubMed ID: 22647872
[TBL] [Abstract][Full Text] [Related]
20. Basic understanding of gonadotropin-releasing hormone-agonist triggering.
Casper RF
Fertil Steril; 2015 Apr; 103(4):867-9. PubMed ID: 25712575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]